Event
19 June, 2023
12:00 pm - 1:00 pm

From petri dish to population: establishing the UK as a clinical trials superpower

The pandemic demonstrated the strength of the UK's life sciences offer, with the successful development of a COVID-19 vaccine at remarkable speed. A range of factors – regulatory flexibility, significant resourcing and a world-class research base – underpinned this, but it was also a product of an incredibly effective clinical trials process. By rapidly recruiting volunteers to test potential vaccines, the UK delivered a breakthrough that saved countless lives. 

Beyond the pandemic, building on this success is essential. As a life sciences leader with a universal healthcare system, the UK has a unique opportunity to punch above its weight in medical innovation. But after a 44% drop in recruitment to commercial clinical trials between 2017 – 2021 (a key issue being explored by the O’Shaughnessy review), strengthening our reputation as a global leader in this space requires decisive action. The potential prize – for patients, the healthcare system and our economy – is too important to be missed. 

Reform is delighted to welcome George Freeman MP, Minister for Science, Innovation and Technology, to lead this private roundtable and discuss the Government's plans to establish the UK as a clinical trials superpower. 

This private roundtable will be held in-person and will take place under the Chatham House rule. This event is kindly supported by Moderna.